FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2322433102> ?p ?o ?g. }

• W2322433102 endingPage "606" @default.
• W2322433102 startingPage "599" @default.
• W2322433102 abstract "Objective Phase 3 trials have demonstrated a survival advantage for patients with optimally debulked epithelial ovarian cancer who received intravenous (IV) and intraperitoneal (IP) chemotherapy compared with IV therapy alone. This was despite a significant proportion of patients in the IV/IP arms not completing all 6 planned cycles. Our objective was to evaluate the prognostic significance of the number of IV/IP cycles administered. Methods/Materials Data were analyzed for all patients with stage III to IV epithelial ovarian cancer who underwent optimal primary cytoreduction followed by 1 or more cycles of IV/IP chemotherapy from January 2005 to July 2011 at our institution. A landmark analysis was performed to associate progression-free survival (PFS) and overall survival (OS) with the number of IV/IP cycles given. Results We identified 201 patients; 26 (13%) received 1 to 2 cycles of IV/IP chemotherapy, 41 (20%) received 3 to 4 cycles, and 134 (67%) received 5 to 6 cycles. The 5-year PFS for patients who received 1 to 2, 3 to 4, and 5 to 6 cycles was 18%, 29%, and 17%, respectively. The 5-year OS for patients who received 1 to 2, 3 to 4, and 5 to 6 cycles was 44%, 54%, and 57%, respectively. There was no significant difference in PFS ( P = 0.31) or OS ( P = 0.14) between the 3 groups. The most common reason for discontinuing IV/IP therapy was treatment-related toxicity (77%). Postoperative complications were the most common reason for not initiating IV/IP therapy (42%) in patients who subsequently transitioned to it. Conclusions We did not detect a significant survival difference between patients who received 1 to 2, 3 to 4, or 5 to 6 IV/IP chemotherapy cycles. Women may still derive a survival benefit if they receive fewer than 6 IV/IP cycles." @default.
• W2322433102 created "2016-06-24" @default.
• W2322433102 creator A5000566519 @default.
• W2322433102 creator A5001429608 @default.
• W2322433102 creator A5046393441 @default.
• W2322433102 creator A5048186556 @default.
• W2322433102 creator A5053852463 @default.
• W2322433102 creator A5055471313 @default.
• W2322433102 creator A5063000921 @default.
• W2322433102 creator A5075806320 @default.
• W2322433102 creator A5081469132 @default.
• W2322433102 creator A5086908552 @default.
• W2322433102 date "2015-05-01" @default.
• W2322433102 modified "2023-09-23" @default.
• W2322433102 title "Prognostic Significance of the Number of Postoperative Intraperitoneal Chemotherapy Cycles for Patients With Advanced Epithelial Ovarian Cancer" @default.
• W2322433102 cites W1849884743 @default.
• W2322433102 cites W1922469696 @default.
• W2322433102 cites W1978927192 @default.
• W2322433102 cites W1982507522 @default.
• W2322433102 cites W2012119996 @default.
• W2322433102 cites W2016888963 @default.
• W2322433102 cites W2020748234 @default.
• W2322433102 cites W2022157561 @default.
• W2322433102 cites W2029069130 @default.
• W2322433102 cites W2098292010 @default.
• W2322433102 cites W2099521317 @default.
• W2322433102 cites W2107402595 @default.
• W2322433102 cites W2113122060 @default.
• W2322433102 cites W2130941707 @default.
• W2322433102 cites W2135947389 @default.
• W2322433102 cites W2139248078 @default.
• W2322433102 cites W2147539392 @default.
• W2322433102 cites W2154175915 @default.
• W2322433102 cites W2169961966 @default.
• W2322433102 cites W2219978888 @default.
• W2322433102 cites W2316501478 @default.
• W2322433102 cites W4233920089 @default.
• W2322433102 doi "https://doi.org/10.1097/igc.0000000000000389" @default.
• W2322433102 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4408230" @default.
• W2322433102 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25664437" @default.
• W2322433102 hasPublicationYear "2015" @default.
• W2322433102 type Work @default.
• W2322433102 sameAs 2322433102 @default.
• W2322433102 citedByCount "12" @default.
• W2322433102 countsByYear W23224331022016 @default.
• W2322433102 countsByYear W23224331022018 @default.
• W2322433102 countsByYear W23224331022019 @default.
• W2322433102 countsByYear W23224331022020 @default.
• W2322433102 countsByYear W23224331022021 @default.
• W2322433102 countsByYear W23224331022022 @default.
• W2322433102 countsByYear W23224331022023 @default.
• W2322433102 crossrefType "journal-article" @default.
• W2322433102 hasAuthorship W2322433102A5000566519 @default.
• W2322433102 hasAuthorship W2322433102A5001429608 @default.
• W2322433102 hasAuthorship W2322433102A5046393441 @default.
• W2322433102 hasAuthorship W2322433102A5048186556 @default.
• W2322433102 hasAuthorship W2322433102A5053852463 @default.
• W2322433102 hasAuthorship W2322433102A5055471313 @default.
• W2322433102 hasAuthorship W2322433102A5063000921 @default.
• W2322433102 hasAuthorship W2322433102A5075806320 @default.
• W2322433102 hasAuthorship W2322433102A5081469132 @default.
• W2322433102 hasAuthorship W2322433102A5086908552 @default.
• W2322433102 hasBestOaLocation W23224331021 @default.
• W2322433102 hasConcept C121608353 @default.
• W2322433102 hasConcept C126322002 @default.
• W2322433102 hasConcept C141071460 @default.
• W2322433102 hasConcept C143998085 @default.
• W2322433102 hasConcept C146357865 @default.
• W2322433102 hasConcept C151730666 @default.
• W2322433102 hasConcept C2776694085 @default.
• W2322433102 hasConcept C2780427987 @default.
• W2322433102 hasConcept C29730261 @default.
• W2322433102 hasConcept C2992773878 @default.
• W2322433102 hasConcept C3019894029 @default.
• W2322433102 hasConcept C3019901188 @default.
• W2322433102 hasConcept C71924100 @default.
• W2322433102 hasConcept C86803240 @default.
• W2322433102 hasConceptScore W2322433102C121608353 @default.
• W2322433102 hasConceptScore W2322433102C126322002 @default.
• W2322433102 hasConceptScore W2322433102C141071460 @default.
• W2322433102 hasConceptScore W2322433102C143998085 @default.
• W2322433102 hasConceptScore W2322433102C146357865 @default.
• W2322433102 hasConceptScore W2322433102C151730666 @default.
• W2322433102 hasConceptScore W2322433102C2776694085 @default.
• W2322433102 hasConceptScore W2322433102C2780427987 @default.
• W2322433102 hasConceptScore W2322433102C29730261 @default.
• W2322433102 hasConceptScore W2322433102C2992773878 @default.
• W2322433102 hasConceptScore W2322433102C3019894029 @default.
• W2322433102 hasConceptScore W2322433102C3019901188 @default.
• W2322433102 hasConceptScore W2322433102C71924100 @default.
• W2322433102 hasConceptScore W2322433102C86803240 @default.
• W2322433102 hasIssue "4" @default.
• W2322433102 hasLocation W23224331021 @default.
• W2322433102 hasLocation W23224331022 @default.
• W2322433102 hasLocation W23224331023 @default.
• W2322433102 hasLocation W23224331024 @default.
• W2322433102 hasOpenAccess W2322433102 @default.
• W2322433102 hasPrimaryLocation W23224331021 @default.

• next